Citadel Advisors - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 53 filers reported holding ENZON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$28,000
-56.9%
29,174
-46.3%
0.00%
Q2 2015$65,000
+160.0%
54,347
+132.5%
0.00%
Q3 2014$25,000
-95.7%
23,379
-95.8%
0.00%
-100.0%
Q1 2014$579,000
+291.2%
562,822
+342.3%
0.00%
Q4 2013$148,000
-65.2%
127,249
-49.6%
0.00%
-100.0%
Q3 2013$425,000
+123.7%
252,501
+165.2%
0.00%
Q2 2013$190,00095,2290.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Ancora Advisors LLC 50,000$20,0000.00%
MONARCH CAPITAL MANAGEMENT INC/ 10,000$4,0000.00%
ACADIAN ASSET MANAGEMENT LLC 122,287$50,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 254,200$103,0000.00%
TUDOR INVESTMENT CORP ET AL 47,998$19,0000.00%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 11,181$5,0000.00%
Kistler-Tiffany Companies, LLC 825$00.00%
Tradewinds Capital Management, LLC 200$00.00%
NEXT Financial Group, Inc 60$00.00%
CT Financial Advisors LLC 2,000$810,0000.00%
View complete list of ENZON PHARMACEUTICALS INC shareholders